News from NYU Langone Health
NYU Langone Health Earns Quarterly Profit As Hospital Discharges, Surgeries Increase. (Crain's New York Business)
(7/25) NYU Langone Health reported substantial profits in the third quarter of its fiscal year, with a nearly 9% operating margin, driven by increased hospital discharges and outpatient surgeries, as stated by Joseph J. Lhota, executive vice president and vice dean, chief financial officer, chief of staff, who said, “Volume is up across the board,” particularly at NYU Langone Hospital – Suffolk, which saw a 26% increase in inpatient discharges and a 17% rise in ambulatory surgeries following its merger with the health system in March. However, the overall margin is reduced to 3.2% when including its two medical schools that operate at a loss.
Also reporting is (7/24).
Jets Get Best-Case Scenario As Justin Fields’ Injury Revealed After Cart Scare. (New York Post)
The (7/24) Daniel J. Kaplan, MD, assistant professor, Department of Orthopedic Surgery, provided insights to The Post regarding Justin Fields’ dislocated toe injury, explaining that since the injury is not to the big toe, “Smaller toe, smaller deal, so I think day-to-day is probably accurate. One week – at most two.”
New Research Shows Lifestyle Changes May Reduce Fibroids. (CBS News)
(7/24) Uterine fibroids affect up to 80% of women by age 50, and Taraneh Shirazian, MD, associate professor, Department of Obstetrics and Gynecology, says a new NYU Langone Health study shows lifestyle changes such as normal vitamin D levels, anti-inflammatory diets, and exercise can prevent or lessen fibroid growth.
Also reporting is (7/24).
Family History Shapes Psoriatic Disease Onset In PsA. (Medscape)
(7/24) A study published July 14, in Arthritis & Rheumatology led by Catherine Howe, MD, Department of Medicine, Division of Rheumatology, found patients with a family history of psoriatic disease were diagnosed with psoriasis and psoriatic arthritis earlier and had more entheseal involvement.
IHC Testing May Enable Expedited Identification Of TP53-Mutant MDS And AML. (OncLive)
(7/24) A study led by Jonathan M. Gerber, MD, member of the faculty, Department of Medicine, Division of Hematology and Medical Oncology, chief, chief clinical officer, Perlmutter 鶹Ƶapp Center, and Shyam A. Patel, MD, PhD, from UMass Memorial Medical Center, explored using immunohistochemistry (IHC) for early detection of multi-hit TP53 mutations in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), identifying a 7% IHC threshold correlating with multi-hit TP53 status, which could expedite treatment decisions and stem cell transplants; Gerber stated, “Knowing a [patient’s] TP53 mutation status as early as possible allows us to divert patients into the appropriate therapies and begin transplant planning,” emphasizing the test’s potential to reduce decision-making time significantly.
Pharmacists Weigh Promise And Challenges Of Finerenone For Patients With HFpEF. (Pharmacy Times)
(7/24) Pharmacists are increasingly involved in managing heart failure with preserved ejection fraction (HFpEF), particularly with the potential introduction of finerenone, a nonsteroidal mineralocorticoid receptor antagonist, which has shown promise in the FINEARTS-HF trial for reducing outpatient worsening heart failure events and atrial fibrillation; Tania Ahuja, PharmD, clinical assistant professor, Department of Medicine, the Leon H. Charney Division of Cardiology, said that although more real-world data are needed, it is a significant step toward expanded options for HFpEF.
Telisotuzumab Vedotin Represents A New Treatment Development For C-Met–Overexpressing NSCLC: With Joshua K Sabari, MD. (OncLive)
(7/24) In a recent episode of OncLive On Air, Joshua K. Sabari, MD, assistant professor, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter 鶹Ƶapp Center, discussed the use of telisotuzumab vedotin-tllv (Emrelis) in c-MET–overexpressing, nonsquamous, EGFR wild-type advanced non–small cell lung cancer (NSCLC).
Full-Body MRI Scans: Peace Of Mind For Some, “Bane Of My Existence” For Others. (Axios)
(7/24) While full-body MRI scans are touted by some as an early detection breakthrough for conditions like cancer, aneurysms, and metabolic disorders, Marleen I. Meyers, MD, clinical professor, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter 鶹Ƶapp Center, says they are “the bane of my existence”, noting the scans are largely unnecessary and potentially harmful due to the high rate of false positives, benign findings, and the stress and cost associated with follow-up procedures.
10 Medical Schools Where Graduates Incur The Most, Least Debt: 2025. (Becker's Hospital Review)
(7/24) The Association of American Medical Colleges found that medical school graduates of 2024 incurred an average of $212,341 in educational debt, with some schools exceeding $300,000, while NYU Grossman School of Medicine and NYU Grossman Long Island School of Medicine graduates reported some of the lowest average debt levels, $67,572 and $51,415 respectively.
(7/24) also covers the story.
5 Pro Athletes Undergoing Orthopedic Surgery. (Becker's Orthopedic & Spine Review)
(7/24) NYU Langone Health’s NYU Langone Sports Medicine Center in New York City played a critical role in recent orthopedic surgeries for professional athletes, with Jonathan L. Glashow, clinical associate professor, Department of Orthopedic Surgery, Sports Medicine Center, performing arthroscopic surgery on Philadelphia 76ers center Joel Embiid’s left knee in April and conducting knee surgery on Philadelphia 76ers player Paul George on July 14.
The Next Generation Of At-Home 鶹Ƶapp Screening Tests. (Health Central)
(7/24) The latest generation of at-home cancer screening tests, including the FDA-approved Teal Wand for cervical cancer and the Shield test for colorectal cancer, offer potential benefits such as convenience, improved accessibility, and increased privacy, though Aasma Shaukat, MD, MPH, the Robert M. and Mary H. Glickman Professor of Medicine, Department of Medicine, Division of Gastroenterology and Hepatology, professor, Department of Population Health, emphasizes that these tests should complement, not replace, traditional screenings like colonoscopies, as they may not be suitable for high-risk individuals and could lead to false positives or negatives.
NYU Langone Health Physician Discusses Artificial Sweeteners. (WNYW-TV New York)
(7/24) Purvi S. Parikh, MD, clinical assistant professor, Department of Pediatrics, Division of Pediatric Allergy & Immunology, and Department of Medicine, Division of Infectious Diseases, Allergy and Immunology, discussed a study on artificial sweeteners, explaining that they are 600 times sweeter than sugar, which tricks the brain into expecting high-calorie intake, leading to increased hunger and cravings for unhealthy foods, and suggested avoiding artificial sweeteners due to potential links to cancer and cardiovascular events, while recommending regular sugar in moderation.
Here’s What Happens When Someone Goes Into Cardiac Arrest. (HuffPost)
(7/24) Lawrence Phillips, MD, associate professor, Department of Medicine, the Leon H. Charney Division of Cardiology, emphasized the importance of taking action when someone goes into cardiac arrest, saying, “The prompt administration of CPR can double or triple likelihood of survival by getting oxygen back to the body.”
Good News: You Don’t Need To Hit 10,000 Steps A Day To Be ‘Healthy.’ (SELF Magazine)
(7/24) Research published in The Lancet Public Health suggests that achieving 5,000 to 7,000 steps daily can significantly reduce risks of various health conditions, such as cardiovascular disease and type 2 diabetes, compared to those taking only 2,000 steps, with minimal benefits beyond 7,000 steps; Thea Gallagher, PsyD, clinical associate professor, Department of Psychiatry, said that regular movement releases neurotransmitters like dopamine and serotonin, which can alleviate depression symptoms, highlighting the importance of integrating enjoyable movement into daily routines rather than focusing solely on hitting high step counts.
(7/24) Art Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor of Bioethics, Department of Population Health, Division of Medical Ethics, discussed the well-known 10,000 steps goal on Mendte in the Morning, expressing his dislike for it by explaining, “10,000 steps is about 5 ½ miles; that would be a lot to walk every day and at an average pace you’d have to walk for 2 hours,” which he believes discourages people, leading them to give up or do nothing; instead, he advises, “Walk as far as you can, when you can. Try to do it, you don’t have to worry about 10,000 steps, 7,000 steps, just do some movement.”
How Common Are Psychiatric Disorders In IBD? (Health Central)
(7/24) A recent study published in Crohn’s & Colitis 360 reveals that over half of individuals with inflammatory bowel disease (IBD) also contend with psychiatric disorders, such as depression, anxiety, OCD, bipolar disorder, PTSD, or substance use disorder, with more than a quarter having multiple conditions; Simon J. Hong, MD, clinical associate professor, Department of Medicine, Division of Gastroenterology and Hepatology, Inflammatory Bowel Disease Center, said this prevalence might be due to the significant impact of IBD on quality of life, particularly as it often manifests in young adults who have not previously dealt with chronic illnesses.
Got High A1C Levels? Stop Doing This One Thing ASAP. (Parade Magazine)
(7/24) Priya Jaisinghani, MD, clinical assistant professor, Department of Medicine, the Holman Division of Endocrinology, Diabetes, & Metabolism, advises that “Portion control and consistent meal timing help reduce glucose variability throughout the day,” and that managing stress levels, good hydration, and quality sleep are also important for managing A1C levels.
First Came Ozempic Face. Now People Are Dealing With Ozempic Hair And Muscle Loss. (Vogue)
(7/24) Holly F. Lofton, MD, clinical associate professor, Departments of Surgery, Division of Bariatric Surgery, and Medicine, Division of General Internal Medicine and Clinical Innovation, described the muscle loss associated with medications like Wegovy and Zepbound, saying they cause similar or greater muscle loss compared to traditional weight-loss methods, with studies indicating 25% of weight loss from these drugs is lean muscle mass, and emphasized the importance of resistance training and adequate protein intake to mitigate this effect.
